Observational study / 2011
Phosphatidylcholine metabolites choline, TMAO, and betaine were linked to cardiovascular disease risk in a clinical cohort.
Using a metabolomics approach, researchers identified three metabolites of dietary phosphatidylcholine—choline, trimethylamine N-oxide (TMAO), and betaine—that predicted CVD risk in a large clinical cohort. In mice, supplementation with choline, TMAO, or betaine promoted upregulation of macrophage scavenger receptors, while choline or TMAO enhanced atherosclerosis. Germ-free mouse studies confirmed gut flora's role in TMAO production and foam cell formation, and suppressing microflora inhibited choline-enhanced atherosclerosis.
Shows an association, not proof of cause and effect.
- Study type
- Metabolomics and prospective cohort study combined with mouse models
- Who was studied
- An independent large clinical cohort (sample size not specified) and mice
- What was measured
- Prediction of CVD risk; macrophage scavenger receptor levels and atherosclerosis
THE PAPER
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL. Nature, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.